Development and characterization of liposomal formulation of bortezomib

Bortezomib is a proteasome inhibitor used for the treatment of multiple myeloma. The poor pharmacokinetic profile and off-target adverse effects provide a strong incentive to develop drug delivery systems for bortezomib. In the past, liposomal encapsulation has been proven to improve the therapeutic...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Anil K. Deshantri (Dahkki), Josbert M. Metselaar (Dahkki), Stavroula Zagkou (Dahkki), Gert Storm (Dahkki), Sanjay N. Mandhane (Dahkki), Marcel H.A.M. Fens (Dahkki), Raymond M. Schiffelers (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Elsevier, 2019-12-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis